The Federal Court of Appeal of Canada in Toronto has blocked Teva's Novopharm to launch its form of Celebrex in Canada according to Pfizer statement on May 1st .

This ruling will prevent Teva Pharmaceutical Industries Ltd. from launching a copycat form of its Celebrex arthritis drug in the country until 2014.

sai's blog
Login or register to post comments
Read more

Information Zone

- Drug Information (1)
- Free books (10)
- Guidance Documents (3)
- Pharmaceutical Journals (4)
- Pharmacists zone (13)
- PEBC Info (4)
- Regulatory Zone (3)

Articles

- Analysis (89)
- Analytical Method Development Articles (23)
- Capillary Electrophoresis Articles (7)
- cGMP Articles (6)
- Chemistry Articles (527)
- Cleaning Validation Articles (45)
- Clinical Pharmacy Articles (590)
- Clinical Trials Articles (331)
- Coating Articles (36)
- Drug Development Articles (280)
- Equipment Validation Articles (11)
- Excipients (14)
- FDA Articles (197)
- Fluid Bed Granulation Articles (29)
- Formulation and Process Development Articles (1707)
- General Articles (463)
- GLP Articles (4)
- HPLC and GC Articles (788)
- Liquids (21)
- Manufacturing Articles (22)
- Mass Spectroscopy Articles (40)
- Natural Products Articles (38)
- News Articles (521)
- Nutraceuticals Articles (6)
- Outsourcing Articles (86)
- Patents Articles (48)
- Pharma Career Articles (218)
- Pharma IT Articles (60)
- Pharmaceutical Packaging Articles (24)
- Pharmaceutical Sales and Marketing Articles (913)
- Process Validation Articles (1)
- Quality Assurance Articles (81)
- Regulatory Articles (73)
- Research and Development Articles (12)
- Stability Articles (17)
- Tabletting Articles (28)
- Validation Articles (66)
- Veterinary Drugs (7)

Videos

Who's online

Pharma Jobs

Forensic Pharmacy Books for GATE examination

See also

Books for GATE Exam by Subject

Review Articles:

Pharma News:

News

Pharma Student Magazine

Reviews

Pharma Blogs

Pfizer Wins against Novopharm on Celebrex Patent Decision in Canadian Court

Information Zone

Articles